COVID-19 Update
Has COVID-19 impacted your patient’s ability to pay for Taltz? We’re here to help. Have your patient contact Taltz Together at 1-844-TALTZ NOW (1-844-825-8966) for information on savings and support.
Questions about Coronavirus? Click here
FOR COMMERCIALLY INSURED PATIENTS
Prescribe with Confidence. Your Patients are Covered.
Expanding Commercial Coverage
More commercial insurance plans than ever are offering Taltz as the Preferred IL-17A antagonist.*
Patients with commercial coverage for Taltz pay as little as $5 with the Taltz Clear Access Program.

Complete a Taltz Together Enrollment Form or send the prescription directly to an Enhanced Specialty Pharmacy to start your patients on Taltz.
How to Enroll | Enrollment Form | Taltz Enhanced Specialty Pharmacy Network | Sample Letters
Contact your sales representative for local plan information and patient support resources.
INDICATIONS
Taltz is indicated for adults with active psoriatic arthritis (PsA), for adults with active ankylosing spondylitis (AS), and for adults with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation. Taltz is also indicated for patients aged 6 years or older with moderate-to-severe plaque psoriasis (PsO) who are candidates for systemic therapy or phototherapy.
SELECT IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
Taltz is contraindicated in patients with a previous serious hypersensitivity reaction, such as anaphylaxis, to ixekizumab or to any of the excipients.
*Source: Data on File, Lilly USA, LLC, DOF-IX-US-0243
†Terms and Conditions: Offer good until 12/31/2024 or for up to 36 months from patient qualification into the program, whichever comes first. Patients must first use their card by 12/31/2021. Patients must have coverage for Taltz through their commercial drug insurance to pay as little as $5 for a 28-day supply of Taltz. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap set at Lilly’s sole discretion. Patients must have commercial drug insurance and prescription consistent with FDA-approved product labeling to pay as little as $25 for 28-day supply of Taltz. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap of wholesale acquisition cost plus usual and customary pharmacy charges. Participation in the $25 program requires submission of a prior authorization (PA). If coverage is denied, an appeal must be submitted prior to 5th month fill. A new PA and appeal or medical exception (ME) must be submitted every 12 months or as required by Lilly to verify coverage status and potential eligibility for the $5 program. Participation in the program requires a valid patient HIPAA authorization. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. This offer is invalid for patients without commercial drug insurance or whose prescription claims for Taltz are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state patient or pharmaceutical assistance program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation is required. Subject to additional terms and conditions, which can be found here.
Other product/company names are the property of their respective owner.
ǂContingent upon a patient scheduling a delivery with a specialty pharmacy.
§Constitutes that a prior authorization has been submitted.
ǁShipment can be authorized within 2 business days of submitting a prescription to either a participating specialty pharmacy or Taltz Together™ and commercial insurance is verified; patient enrolls in the Taltz Savings Card program and schedules shipment.